The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2015

Filed:

Mar. 24, 2005
Applicants:

Klaus Pfizenmaier, Tiefenbronn, DE;

Peter Scheurich, Stuttgart, DE;

Ingo Grunwald, Bremen, DE;

Anja Krippner-heidenreich, Newcastle upon Tyne, GB;

Inventors:

Klaus Pfizenmaier, Tiefenbronn, DE;

Peter Scheurich, Stuttgart, DE;

Ingo Grunwald, Bremen, DE;

Anja Krippner-Heidenreich, Newcastle upon Tyne, GB;

Assignee:

Universitat of Stuttgart, Stuttgart, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/49 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/543 (2006.01); C07K 14/525 (2006.01); A61K 45/06 (2006.01); C07K 14/705 (2006.01); C07K 16/40 (2006.01); G01N 33/544 (2006.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/525 (2013.01); G01N 33/53 (2013.01); A61K 45/06 (2013.01); C07K 14/70575 (2013.01); C07K 16/40 (2013.01); G01N 33/543 (2013.01); G01N 33/544 (2013.01); G01N 33/6863 (2013.01); G01N 2333/525 (2013.01); A61K 38/00 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); Y10S 530/811 (2013.01); Y10S 530/812 (2013.01);
Abstract

The invention relates to polypeptides comprising, as constituent A, at least three monomers of a member of the TNF ligand family and, as constituent B, at least two peptide linkers that link the monomers of the member of the TNF ligand family to one another. The invention also relates to the use of these polypeptides for treating diseases and for producing a medicament or a vaccine. The invention also relates to methods for producing and isolating these polypeptides, to nucleic acids that code for these polypeptides, to vectors containing these nucleic acids, to host cells transfected with these vectors, and to pharmaceutical compositions containing these inventive objects. Finally, the invention relates to methods for the extracorporeal manipulation, depletion and/or removal of components contained in body fluids, e.g. by means of apheresis.


Find Patent Forward Citations

Loading…